| |
|
|
PRIMARY MISSION:
To prevent, treat, and cure antiphospholipid antibody (aPL) associated clinical manifestations through high-quality, multicenter, and multidisciplinary clinical research.
SECONDARY MISSION:
To refine and advance the definitions of aPL associated clinical manifestations through international collaboration and data sharing.
APPROACH:
Members are working together to create a research alliance that will design and conduct clinical trials, and collect data via an international registry.
|
|
